JAGX vs TECH · rev $11.5M vs P/E 65, rev $1.22B
Jaguar Animal Health Inc (JAGX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported JAGX revenue for 2025-12-31 was $11.5M. Net income was -$53.6M. Revenue was down 1.5% from 2024-12-31 to 2025-12-31. JAGX currently screens at market cap $1.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
JAGX currently screens at market cap $1.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the JAGX and TECH stock pages for the full models.
Not investment advice.